Teijin Carbon provides advanced carbon fiber products and high-performance solutions, self-described as a leading manufacturer in this sector.

Teijin Carbon

AI in Pharma: Discovery is focused on exploring the applications of AI-based technology in drug discovery and development, specifically how AI, ML, NLP, data science, and generative deep learning models can optimize the pharmaceutical and biotechnology industries.

AI in Pharma: Discovery

Smile AI focuses on increasing online sales through its platform tailored for pharmaceutical e-commerce, self-described as a leader in the industry.

Metric
Company Name	Teijin Carbon	AI in Pharma: Discovery	Smile AI
Symbol
MSH ID	COM:TEIJINCARBON	COM:AIINPHARMA-DISCOVERY	DE:SMILEAI
Market	PRIVATE	PRIVATE	PRIVATE
Sector	Basic Materials & Materials	Healthcare & Health Services	Technology
Industry	Manufacturing	Pharmaceuticals	Pharmaceutical E-Commerce
Country	DE	US	DE
Stage			Seed
Employee Count
Website	teijincarbon.com	aiinpharma-discovery.com	smileai.de
LinkedIn			smileai
Founders

Metric
Market Cap
Enterprise Value
Monthly Web Traffic	9.14K
Web Traffic Growth	1.67
Valuation
Raised Capital		113.32K

Metric
Revenue
Revenue (LTM)
Revenue (NTM)
Gross Profit
EBITDA
Operating Income
Net Income
EPS
Diluted EPS
Revenue 2022
Revenue 2023
Revenue 2024
Revenue 2025
Revenue 2026

Metric
Revenue Growth (LTM)
Revenue Growth (NTM)
Gross Profit Growth (LTM)
EBITDA Growth (LTM)
Net Income Growth (LTM)
14-Day Growth Score
28-Day Growth Score
90-Day Growth Score
365-Day Growth Score

Metric
Gross Profit Margin
Operating Profit Margin
EBITDA Margin
Net Profit Margin
Return on Equity
Return on Assets
Return on Capital Employed

TEIJ

COM:TEIJINCARBON

Teijin Carbon

Company Overview

Market Metrics

Financial Performance

Growth Metrics

Profitability Ratios

Valuation Multiples

Operational Metrics

Cash Flow Metrics

Balance Sheet Metrics

Efficiency Metrics

Metric
P/E Ratio
P/B Ratio
Revenue Multiple (LTM)
Revenue Multiple (NTM)
EBITDA Multiple (LTM)
EBITDA Multiple (NTM)
Price to Sales Ratio
EV Multiple

Metric
Days Sales Outstanding
Days Payables Outstanding
Days Inventory Outstanding
Operating Cycle
Cash Conversion Cycle
Asset Turnover

Metric
Operating Cash Flow
Free Cash Flow
Cash Flow to Debt
Operating Cash Flow/Sales
Free Cash Flow Yield

Metric
Cash & Equivalents
Accounts Receivable
Inventory
Goodwill
Debt to Capitalization
Debt to Assets
Current Ratio
Quick Ratio

Metric
Rule of 40 (LTM)
Rule of 40 (NTM)
Stock Comp to Revenue
R&D to Revenue
SG&A to Revenue